Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

243 ARTÍCULOS , VIENDO DEL 166 AL 180

The Link Between Amitriptyline and Movement Disorders: Clinical Profile and Outcome

Rissardo JP, Caprara ALF.

Ann Acad Med Singap. 2020 Apr;49(4):236-251.

Sporadic Creutzfeldt-Jakob Disease: Case Report and Literature Review

Filatov A, Khanni JL, Alusma-Hibbert K, Espinosa PS.

Cureus. 2020 Apr 21;12(4):e7767. doi: 10.7759/cureus.7767.

Clinical and genetic characteristics of type I sialidosis patients in mainland China

Lv RJ, Li TR, Zhang YD, Shao XQ, Wang Q, Jin LR.

Ann Clin Transl Neurol. 2020 Jun;7(6):911-923. doi: 10.1002/acn3.51058. Epub 2020 May 29.

The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases

Naumchik BM, Gupta A, Flanagan-Steet H, Steet RA, Cathey SS, Orchard PJ, Lund TC.

Cells. 2020 Jun 5;9(6):1411. doi: 10.3390/cells9061411.

Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature

Sena G, Gallo G, Vescio G, Gambardella D, de Franciscis S, Renne M.

J Med Case Rep. 2020 Jun 12;14(1):67. doi: 10.1186/s13256-020-02410-z.

Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation

De Michele G, Galatolo D, Lieto M, Fico T, Saccà F, Santorelli FM, Filla A.

Parkinsonism Relat Disord. 2020 Jul;76:42-43. doi: 10.1016/j.parkreldis.2020.06.001. Epub 2020 Jun 7.

Glucose transporter type 1 deficiency syndrome associated with autoantibodies to glutamate receptors

Hoshino H, Takayama K, Ishii A, Takahashi Y, Kanemura H.

Brain Dev. 2020 Oct;42(9):686-690. doi: 10.1016/j.braindev.2020.05.010. Epub 2020 Jun 24.

Progressive Myoclonic Epilepsy Type 1

Lehesjoki AE, Kälviäinen R.

2004 Jun 24 [updated 2020 Jul 2]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

[Virus-induced opsoclonus-myoclonus syndrome during pregnancy]

Alekseeva TM, Topuzova MP, Skripchenko NV, Simakov KV, Senkevich KA, Novozhilova MA, Agapova OY, Ternovykh IK, Chaykovskaya AD.

Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(5):93-99. doi: 10.17116/jnevro202012005193.

Paraneoplastic Cerebellar Degeneration Secondary to BRAF Mutant Melanoma Metastasis from an Occult Primary Cancer

Jiménez-Zarazúa O, Vélez-Ramírez LN, Alcocer-León M, Hernández-Domínguez DA, Tadeo-González JE, Martínez-Rivera MA, López-González MDA, Tafoya-Rojas SXL, Mondragón JD.

Case Rep Oncol. 2020 Jun 11;13(2):633-642. doi: 10.1159/000507729. eCollection 2020 May-Aug.

An unusual case of opsoclonus-myoclonus-ataxia syndrome associated neuroblastoma: High-risk disease requiring immunotherapy

Stiefel J, Basu E, Meyer R, Kaur G, Khakoo Y.

Pediatr Blood Cancer. 2020 Nov;67(11):e28393. doi: 10.1002/pbc.28393. Epub 2020 Aug 15.

Rett Syndrome as a movement and motor disorder - A narrative review

Brunetti S, Lumsden DE.

Eur J Paediatr Neurol. 2020 Sep;28:29-37. doi: 10.1016/j.ejpn.2020.06.020. Epub 2020 Jul 28.

Myoclonus and Cerebellar Ataxia Following COVID-19

Dijkstra F, Van den Bossche T, Willekens B, Cras P, Crosiers D.

Mov Disord Clin Pract. 2020 Sep 28;7(8):974-976. doi: 10.1002/mdc3.13049. eCollection 2020 Nov.

Movement disorders induced by psychiatric drugs that do not block dopamine receptors

Friedman JH.

Parkinsonism Relat Disord. 2020 Oct;79:60-64. doi: 10.1016/j.parkreldis.2020.08.031. Epub 2020 Aug 26.

Myoclonic tremor status as a presenting symptom of adenylosuccinate lyase deficiency

Andelman-Gur MM, Saitsu H, Matsumoto N, Spiegel R, Yosovich K, Lev D, Lerman-Sagie T, Blumkin L.

Eur J Med Genet. 2020 Dec;63(12):104061. doi: 10.1016/j.ejmg.2020.104061. Epub 2020 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias